ANAC


Biotech Beat: Relypsa Inc (RLYP), Ariad Pharmaceuticals Inc. (ARIA), Anacor Pharmaceuticals Inc (ANAC)

Relypsa Inc In a research report issued today, Wedbush analyst Liana Moussatos weighed in on drug maker Relypsa Inc (NASDAQ:RLYP), after the company released Veltassa (patiromer) …

Monday Morning’s Market Insights: Breitburn Energy Partners LP (BBEP), Nanosphere, Inc. (NSPH), Anacor Pharmaceuticals Inc (ANAC), Trevana Inc (TRVN)

Breitburn Energy Partners LP (NASDAQ:BBEP) is plummeting 58% in pre-market trading after the company filed for Chapter 11 bankruptcy protection. The company claimed …

Anacor Pharmaceuticals Inc (ANAC) May Have A “Home Run” Drug On Its Hands

Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) are soaring thanks to some positive results in two late-stage (Phase 3) trials for a topical ointment …

Wedbush Doubles Price Target For Anacor Pharmaceuticals Inc; Here’s Why

Anacor Pharmaceuticals Inc (NASDAQ:ANAC) shares jumped nearly 56% today after the company announced preliminary positive top-line results from its two Phase 3 pivotal studies of …

Wedbush Reaffirms Outperform On Anacor Following Launch Of Kerydin In The US

In a research note published yesterday, Wedbush analyst David Nierengarten reaffirmed an Outperform rating on Anacor Pharmaceuticals (NASDAQ:ANAC) with a $35 price target, …

Wedbush Reiterates Outperform On Anacor Following Partnership With Sandoz

In a research note published July 18, Wedbush analyst David Nierengarten reiterated an Outperform rating on Anacor Pharmaceuticals (ANAC) and raised his price …

Wedbush Reiterates An Outperform On Anacor Following FDA Approval Of Kerydin

In a research note released yesterday, Wedbush analyst David Nierengarten reiterated an Outperform rating on Anacor Pharmaceuticals (ANAC) with a price target of …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts